ATE82861T1 - Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien. - Google Patents

Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.

Info

Publication number
ATE82861T1
ATE82861T1 AT89107314T AT89107314T ATE82861T1 AT E82861 T1 ATE82861 T1 AT E82861T1 AT 89107314 T AT89107314 T AT 89107314T AT 89107314 T AT89107314 T AT 89107314T AT E82861 T1 ATE82861 T1 AT E82861T1
Authority
AT
Austria
Prior art keywords
liquid
raw materials
physiologically active
biological raw
allergenic compositions
Prior art date
Application number
AT89107314T
Other languages
English (en)
Inventor
Erich Stevens
G M Lejoly
Original Assignee
Tetra Consultants Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetra Consultants Inc filed Critical Tetra Consultants Inc
Application granted granted Critical
Publication of ATE82861T1 publication Critical patent/ATE82861T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89107314T 1988-04-27 1989-04-22 Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien. ATE82861T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3814113A DE3814113A1 (de) 1988-04-27 1988-04-27 Physiologisch aktive fluessige wirkstoff-zubereitungen, insbesondere allergen-zubereitung, aus biologischem ursprungsmaterial
EP89107314A EP0339531B1 (de) 1988-04-27 1989-04-22 Physiologisch aktive, flüssige, allergenische Zusammensetzungen aus biologischen Rohmaterialien

Publications (1)

Publication Number Publication Date
ATE82861T1 true ATE82861T1 (de) 1992-12-15

Family

ID=6352929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89107314T ATE82861T1 (de) 1988-04-27 1989-04-22 Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.

Country Status (5)

Country Link
EP (2) EP0339531B1 (de)
AT (1) ATE82861T1 (de)
DE (2) DE3814113A1 (de)
ES (1) ES2052803T3 (de)
WO (1) WO1989010138A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585391A (en) * 1993-10-08 1996-12-17 Fhj Scientific, Inc. Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents and processes for preparing them
US5679711A (en) * 1993-10-08 1997-10-21 Fhj Scientific, Inc. Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents
US7033589B1 (en) 1997-02-20 2006-04-25 Biogen Idec Ma Inc. γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
US6893636B2 (en) 1997-02-20 2005-05-17 Biogen Idec Ma Inc. Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
CN108129558B (zh) * 2017-12-21 2021-10-12 中国医学科学院北京协和医院 一种桦树花粉主要致敏蛋白Bet v 8的提取和分离纯化方法及应用
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO132132C (de) * 1968-10-10 1975-09-24 David George Marsh
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
US4605557A (en) * 1982-09-07 1986-08-12 Tetra Consultants, Inc. Method of producing allergenic extracts
DE3380398D1 (en) * 1982-09-07 1989-09-21 Tetra Consultants Inc Method of improving parenterally administerable physiologically active compositions by incorporating therein an epsilon-aminocaproic acid or tranexamic acid

Also Published As

Publication number Publication date
DE68903670T2 (de) 1993-06-03
EP0339531A1 (de) 1989-11-02
WO1989010138A1 (en) 1989-11-02
DE3814113A1 (de) 1989-11-09
EP0339531B1 (de) 1992-12-02
ES2052803T3 (es) 1994-07-16
DE68903670D1 (de) 1993-01-14
EP0402418A1 (de) 1990-12-19

Similar Documents

Publication Publication Date Title
FI906204A0 (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
KR890000485A (ko) 캠프토데신 유도체 및 그의 아미노기에 있어서의 산 부가염 및 4급 암모늄염 및 그의 제조방법
SE8604566D0 (sv) Novel compunds
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
DK344882A (da) Fremgangsmaade til fremstilling af substituerede 2-carbamimidoyl-1-carbadethiapen-2-em-carboxylsyrer
SE8603582D0 (sv) Komposition innehallande l-dopa
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
DE3853538D1 (de) Glykosidester und verfahren zur enzymatischen herstellung.
EP0254461A3 (de) Bekämpfung von Pflanzennematoden mittels substituierten Hydrazone
ATE82861T1 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
ATE247475T1 (de) Synthetische gangliosid-derivate
FR2660657B1 (fr) Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
BG92842A (bg) Метод за получаване на бета-карбонил-карбоксиамиди на 1,3-тиазолидини
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
DK443988A (da) Injektionspraeparat indeholdende modificeret tpa
IT8621999A1 (it) Derivati pirido-benzotiazinici ad attività antibatterica ed a lunga durata di azione
ES524524A0 (es) Procedimiento para la preparacion de un aducto de un diisocianato
KR870004038A (ko) 제초제 화합물의 제조방법
FR2655989B1 (fr) Nouveaux derives d'amino-acides substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE133955T1 (de) Acylphosphatester und modifikation von proteinen damit
EP0272240A3 (de) Maleimidharze
ES8507097A1 (es) Procedimiento para incrementar la biomasa vegetal
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler
YU168790A (sh) 2-fluorcklopropil-estri sirćetne kiseline, postupak za njihovo dobijanje i njihova primena kao sredstva protiv štetočina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties